Dr Michelle Maugham-Macan | UniSC | University of the Sunshine Coast, Queensland, Australia

Accessibility links

Non-production environment - https://edittrain.usc.edu.au

Dr Michelle Maugham-Macan

PhD Qld.UT, Bachelor of Biomedical Science (Hons) Qld.UT, Bachelor of Applied Science (Biotechnology) Qld.UT

  • Lecturer, Biomedical Science
Email
Telephone
+61 7 5430 1265
Office location
SD-T-3-3.15
Campus
Sunshine Coast
Michelle Maugham-Macan

Dr Michelle Maugham-Macan joined the School of Health and Behavioural Science at UniSC as a Lecturer in Biomedical Science in February 2020.

Prior to joining UniSC, Michelle worked as an Associate Lecturer in Anatomy and Physiology and Research Fellow at the Australian Centre for Prostate Cancer Research - Queensland, Queensland University of Technology (2018-2020) investigating novel therapeutics that target metabolic syndrome and advanced prostate cancer.

Michelleā€™s current research focuses on the impact of childhood conditions and cancer on bone biology; specifically investigatingĀ the aetiology of early-onset osteoporosis in Down Syndrome and the effect of adipose tissue on bone metastases. Michelle is an active member of the Australian and New Zealand Bone and Mineral Society (ANZBMS), the Endocrine Society of Australia (ESA) and the Trisomy 21 Research Society (T21RS).

Potential research projects for HDR & Honours students

  • Investigating the aetiology of early-onset osteoporosis in Trisomy 21
  • The role of adipose tissue in breast cancer bone metastases

Research areas

  • endocrinology
  • bone biology
  • drug development
  • quality use of medicines
  • cancer research

Available for guest lectures in Physiology, Endocrinology, Bone Biology and Pharmacology

Teaching areas

  • LFS103 Introductory Bioscience
  • LFS112 Human Physiology
  • LFS304 Clinical placement I
  • LFS305 Clinical placement II
  • BIM300 Advanced Professional Skills in Biomedical Science

Dr Michelle Maugham-Macan's specialist areas of knowledge include bone biology, endocrinology, Trisomy 21, drug development and prostate cancer.

More UniSC experts...